dm+d
108979001
Articles
Antiplatelet formulations suggested for adults with swallowing difficulties
1 July 2021A range of antiplatelets are suitable for use in adults with swallowing difficulties.
Safety in Lactation: Drugs for thromboembolic disorders
18 September 2020Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. Oral anticoagulants The coumarin anticoagulants, warfarin…
Anticoagulation for Atrial Fibrillation ‘Perfect’
26 May 2020Anticoagulation is key to reducing the risk of stroke in atrial fibrillation (AF). However ensuring that the anticoagulant is prescribed at the correct dose for…
Chondroitin – what are its drug interactions?
23 January 2020There are two published case reports of increased INR in patients receiving warfarin who self-medicated with glucosamine-chondroitin supplements. INR was increased in a further three…
Do proton pump inhibitors reduce the clinical efficacy of clopidogrel?
25 July 2019This updated Medicines Q&A evaluates the available evidence for an interaction between clopidogrel and proton pump inhibitors Summary Clopidogrel is converted into its active metabolite…
Medicine Compliance Aid Stability
GrepidBeacon Pharmaceuticals
Beacon Pharmaceuticals
Grepid
Tablets 75mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
The tablets should be protected from light.
9 November 2015
genericConsilient Health UK Ltd
Consilient Health UK Ltd
generic
Tablets 75mg
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
Protect from light
Protect from moisture
There are anecdotal reports of clopidogrel hydrochloride tablets becoming brittle and breaking after storage in MCA. The tablets should be protected from light and moisture.
9 November 2015
PlavixSanofi
Sanofi
Plavix
Tablets 75mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from moisture
The tablets should be protected from light and moisture.
9 November 2015
Lactation Safety Information
Aspirin, Dipyridamole
No published evidence of safety
Amount in milk likely to be small based on the drug’s properties
Monitor the infant for signs of bruising or bleeding
7 July 2021